A Qualitative Study of the Treatment Experiences of Autistic Adults Allocated to Sertraline or Placebo for Anxiety in a Blinded Randomised Controlled Trial
This publication is included in the Autistic Autism Scholarship Project. five authors of this publication are identified as autistic in the project.
About the autistic author markerNorris, J. E., Realpe, A. X., Lorenc, A., Cotton, L., Morgan, Z., Rai, D., Mills, N., STRATA Collaboration Group, Alberts, J., Alexander, R., Allender, L., Amiola, A. J., Andrusjak, W., Aujla, S., Baillon, S., Baldwin, D. S., Barbosa, A., Bentley, M., Bhattarai, G.,..., & Young, A. (2026). A Qualitative Study of the Treatment Experiences of Autistic Adults Allocated to Sertraline or Placebo for Anxiety in a Blinded Randomised Controlled Trial. Journal of Autism and Developmental Disorders. https://doi.org/10.1007/s10803-026-07327-y
This publication is integrated into AutiHub through:
Authors
Abstract
Abstract Purpose The STRATA randomised-controlled trial (RCT) examined the antidepressant sertraline vs placebo for treating anxiety in autistic adults. Autistic people are often assumed to be reluctant to take part in RCTs due to intolerance of their inherent uncertainty. This study aimed to qualitatively examine autistic people’s experiences of RCT participation, specifically regarding their random assignment to an antidepressant (sertraline) or placebo for their mental health, whilst blinded to treatment allocation. Methods Semi-structured interviews were undertaken with a purposive sample of 62 STRATA participants. The interviews examined why they chose to take part, why they continued in the trial and/or discontinued medication, and their overall experience of participation. Interviews took place either during participation, or at participants’ final trial appointment at 52-weeks post randomisation (‘exit interviews’). Data were analysed thematically through a collaborative process, with multiple researchers independently coding, discussing, and refining themes. Results Interviewees often discussed improved anxiety, attributing changes to believing they were taking sertraline, experiencing the placebo effect, or external factors. Post-analysis unblinding revealed that improved anxiety was discussed equally by participants in both the sertraline and placebo groups. Some participants, including those taking placebo, experienced side effects, which mirrored the types, frequency, and severity seen in the general population. Many were able to manage these and continue, but some discontinued medication as a result. Conclusion Aspects of trial design and delivery facilitated continuation with the study medication, including frequent appointments, shared control over medication dose, and meaningfully involving autistic people in trial design. Such non-pharmacological factors may enhance therapeutic benefits, and may improve RCT design and therapeutic alliances with autistic people.
Bibliography cited by this reference
Cited references are imported from external metadata sources when they are available. The list may be partial.
Cited bibliography overview
These indicators describe the bibliography cited by this publication. An author name is counted each time it appears in one cited reference, so the same person can be counted more than once. Names not yet linked to an author already present in AutiHub are treated as unknown, not as non-autistic. Last computed: 17 Nov 2026 01:01.
- With a DOI
- 26
- Without a DOI, from raw bibliography text
- 1
- References with detected author names
- 26 / 27 (96.3%)
- Without detected author names
- 1
- Without a structured title
- 2
- Without a stable identifier
- 1
- References with raw author names still to review
- 1
- References with external metadata lookup issues
- 0
- From DOI or external metadata
- 298
- From validated raw bibliography text
- 0
- Raw names already validated
- 0
- Raw names still to review
- 1
-
Virginia Braun , Victoria Clarke (2006). Using thematic analysis in psychology . Qualitative Research in Psychology, 3(2), 77-101. Informa UK Limited.Crossref OpenAlex
-
Claire Anderson , Susan Kirkpatrick , Damien Ridge , Renata Kokanovic , Claire Tanner (2015). Starting antidepressant use: a qualitative synthesis of UK and Australian data . BMJ Open, 5(12), e008636. BMJ.Crossref OpenAlex
-
D. J. Grelotti , T. J. Kaptchuk (2011). Placebo by proxy . BMJ, 343(aug11 2), d4345-d4345. BMJ.Crossref OpenAlex
-
Sheena K. Au‐Yeung , Louise Bradley , Ashley Robertson , Rebecca Shaw , S. Baron-Cohen , Sarah Cassidy (2019). Experience of mental health diagnosis and perceived misdiagnosis in autistic, possibly autistic and non-autistic adults . Autism, 23(6), 1508-1518. SAGE Publications.Crossref OpenAlex
-
Kerry Gibson , Claire Cartwright , John Read (2014). Patient-Centered Perspectives on Antidepressant Use . International Journal of Mental Health, 43(1), 81-99. Informa UK Limited.Crossref OpenAlex
-
Bernhard T Baune , Ioana Florea , Bjarke Ebert , Maëlys Touya , Anders Ettrup , Monica Hadi et al. (2021). Patient Expectations and Experiences of Antidepressant Therapy for Major Depressive Disorder: A Qualitative Study . Neuropsychiatric Disease and Treatment, Volume 17(null), 2995-3006. Informa UK Limited.Crossref OpenAlex
-
Alice Malpass , Alison Shaw , Debbie Sharp , Fiona Walter , Gene Feder , Matthew Ridd et al. (2009). “Medication career” or “Moral career”? The two sides of managing antidepressants: A meta-ethnography of patients' experience of antidepressants . Social Science & Medicine, 68(1), 154-168. Elsevier BV.Type: Journal article DOI: 10.1016/j.socscimed.2008.09.068 OpenAlex: https://openalex.org/W2068630143Crossref OpenAlex
-
Lucy Beasant , Alba X Realpe , Sarah Douglas *Autistic author. Learn more… , Lorcan Kenny , Dheeraj Rai , Nicola Mills (2024). Autistic adults’ views on the design and processes within randomised controlled trials: The APRiCoT study . Autism, 28(6), 1540-1550. SAGE Publications.
-
J. Read , K. Gibson , C. Cartwright , C. Shiels , C. Dowrick , M. Gabbay (2015). Understanding the non‐pharmacological correlates of self‐reported efficacy of antidepressants . Acta Psychiatrica Scandinavica, 131(6), 434-445. Wiley.Crossref OpenAlex
-
Jonathan Price , Victoria Cole , Guy M. Goodwin (2009). Emotional side-effects of selective serotonin reuptake inhibitors: qualitative study . British Journal of Psychiatry, 195(3), 211-217. Royal College of Psychiatrists.Crossref OpenAlex
-
C Davico (2023). Davico, C., Secci, I., Vendrametto, V., & Vitiello, B. (2023). Pharmacological treatments in autism spectrum disorder: A narrative review. Journal of Psychopathology. https://doi.org/10.36148/2284-0249-N251 Journal of Psychopathology.Type: Other DOI: 10.36148/2284-0249-n251Crossref
-
Joshua Nadeau , Michael L Sulkowski , Danielle Ung , Jeffrey J. Wood , Adam B Lewin , Tanya K Murphy et al. (2011). Treatment of comorbid anxiety and autism spectrum disorders . Neuropsychiatry, 1(6), 567-578. OMICS Publishing Group.Crossref OpenAlex
-
Anne Masi , A Lampit , N Glozier , I B Hickie , Adam J Guastella (2015). Predictors of placebo response in pharmacological and dietary supplement treatment trials in pediatric autism spectrum disorder: a meta-analysis . Translational Psychiatry, 5(9), e640-e640. Springer Science and Business Media LLC.Crossref OpenAlex
-
Kerry Gibson , Claire Cartwright , John Read (2016). ‘In my life antidepressants have been…’: a qualitative analysis of users’ diverse experiences with antidepressants . BMC Psychiatry, 16(1), 135-135. Springer Science and Business Media LLC.Crossref OpenAlex
-
Suma Jacob , Jeremy Veenstra‐VanderWeele , Declan Murphy , James McCracken , Janice Smith , Kevin Sanders et al. (2022). Efficacy and safety of balovaptan for socialisation and communication difficulties in autistic adults in North America and Europe: a phase 3, randomised, placebo-controlled trial . The Lancet Psychiatry, 9(3), 199-210. Elsevier BV.Crossref OpenAlex
-
Meng‐Chuan Lai , Caroline Kassee , Richard Besney , Sarah Bonato , Laura Hull , William Mandy et al. (2019). Prevalence of co-occurring mental health diagnoses in the autism population: a systematic review and meta-analysis . The Lancet Psychiatry, 6(10), 819-829. Elsevier BV.Crossref OpenAlex
-
Eva Loth (2022). Placebo effects and participant heterogeneity in clinical trials of autism spectrum disorder . The Lancet Psychiatry, 9(3), 184-185. Elsevier BV.Crossref OpenAlex
-
Victoria Nimmo-Smith , Hein Heuvelman , Christina Dalman , Michael Lundberg , Selma Idring , Peter Carpenter et al. (2020). Anxiety Disorders in Adults with Autism Spectrum Disorder: A Population-Based Study . Journal of Autism and Developmental Disorders, 50(1), 308-318. Springer Science and Business Media LLC.Crossref OpenAlex
-
John Read , Mihaela Grigoriu , Aimee Gee , Jacob Diggle , Helen Butler (2020). The Positive and Negative Experiences of 342 Antidepressant Users . Community Mental Health Journal, 56(4), 744-752. Springer Science and Business Media LLC.Crossref OpenAlex
-
Mariah A. Manter , Kirstin B. Birtwell , James Bath , Nora D. B. Friedman , Christopher J. Keary , Ann M. Neumeyer et al. (2025). Pharmacological treatment in autism: a proposal for guidelines on common co-occurring psychiatric symptoms . BMC Medicine, 23(1), 11-11. Springer Science and Business Media LLC.Crossref OpenAlex
-
Alba X Realpe , Nicola Mills , Lucy Beasant , Sarah Douglas *Autistic author. Learn more… , Lorcan Kenny , Dheeraj Rai (2023). Lockdown Experiences and Views on Future Research Participation of Autistic Adults in the UK During the First 6 Months of the COVID-19 Pandemic . Autism in Adulthood, 5(3), 301-310. SAGE Publications.
-
NVivo. (2012). NVivo qualitative data analysis Software. QSR International Pty Ltd. Version 10.Type: OtherCrossref
-
Cagri Ozpolat , Yagmur Okcay , Kemal Gokhan Ulusoy , Oğuzhan Yildiz (2025). A narrative review of the placebo effect: historical roots, current applications, and emerging insights . European Journal of Clinical Pharmacology, 81(5), 625-645. Springer Science and Business Media LLC.Crossref OpenAlex
-
Dheeraj Rai , Doug Webb , Amanda Lewis , Leonora Cotton , Jade Eloise Norris , Regi Alexander et al. (2024). Sertraline for anxiety in adults with a diagnosis of autism (STRATA): study protocol for a pragmatic, multicentre, double-blind, placebo-controlled randomised controlled trial . Trials, 25(1), 37-37. Springer Science and Business Media LLC.
-
Alba X Realpe , Jade Eloise Norris , Ava Lorenc , Leonora Cotton , Zoe Morgan , Aws Sadik et al. (2026). A Qualitative Study Exploring the Acceptability of Taking Part in a Large Multicentre RCT of Medication for Anxiety in Autistic Adults (the STRATA Trial) . Autism, 30(9), 2318-2333. SAGE Publications.Crossref OpenAlex
-
Aws Sadik , Golam M. Khandaker , Antonio F. Pardiñas , Michael Lundberg , Brian K. Lee , Cecilia Magnusson et al. (2026). Antidepressant Prescribing Trends for Adults With and Without Autism in the United Kingdom From 1997 to 2023: A Population‐Based Cohort Study Using Clinical Practice Research Datalink Aurum . Autism Research, 19(10), e70360-e70360. Wiley.OpenAlex
-
Aws Sadik , Golam M. Khandaker , Antonio F. Pardinas , Michael Lundberg , Brian Lee , Cecilia Magnusson et al. (2025). Antidepressant prescribing trends for adults with and without autism in the United Kingdom from 1997 to 2023, a population-based cohort study using Clinical Practice Research Datalink Aurum . medRxiv. openRxiv.Type: Preprint DOI: 10.1101/2025.10.24.25338725Crossref